3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Other hematologic neoplasm
1
Conditions
Leukemia, Myeloid, Acute
1
Interventions
Cyclophosphamide
10
fludarabine
5
Etoposide
5
venetoclax
3
Stem Cell Transplantation
3
Sirolimus
3
Exercise
3
Cytarabine
3
pembrolizumab
2
Vincristine
2
Transplantation
2
Peripheral Blood Stem Cell Transplantation
2
Methotrexate
2
Magnetic Resonance Spectroscopy
2
Influenza Vaccines
2
Immunotherapy, Adoptive
2
Ifosfamide
2
Idarubicin
2
Granulocyte Colony-Stimulating Factor
2
Filgrastim
2
Doxorubicin
2
Dexamethasone
2
Counseling
2
Cord Blood Stem Cell Transplantation
2
Biopsy
2
Azacitidine
2
siltuximab
1
ruxolitinib
1
pirtobrutinib
1
nilotinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase EARLY_PHASE1
×
Atovaquone
×
Other hematologic neoplasm
×
Clear all
NCT03568994
2026-01-27
ATACC AML
Baylor College of Medicine
Phase EARLY_PHASE1
Completed
26 enrolled